SCINAI IMMUNOTHERAPEUTICS LTD. Deferred Income Revenue Recognized
SCINAI IMMUNOTHERAPEUTICS LTD. (SCNI) reported Deferred Income Revenue Recognized of EUR 5.00 thousand for the 12-month period ending 2025-12-31, per its 20-F filed 2026-04-01.
Financial Statements › Income Statement › Other Income
us-gaap:DeferredIncomeRevenueRecognized · last filed 2026-04-01
EUR
| Period end | Deferred Income Revenue Recognized 12 month |
|---|---|
| 2025-12-31 | 5.00K EUR 20-F · filed 2026-04-01 |
| 2024-12-31 | 5.00K EUR 20-F · filed 2025-05-07 |
USD
| Period end | Deferred Income Revenue Recognized 12 month |
|---|---|
| 2025-12-31 | $5.33M 20-F · filed 2026-04-01 |
| 2024-12-31 | $5.33M 20-F · filed 2025-05-07 |